$85.0M
The round was backed by M&G Investments alongside existing supporters Oxford Science Enterprises, Braavos Investment Advisers, and Lansdowne Partners.
Osler Diagnostics develops portable tabletop blood-testing devices for clinical and decentralized settings.
Osler Diagnostics is an Oxford spinout that has developed a portable tabletop device for rapid blood testing outside of traditional laboratories. The firm employs over 100 people across engineering, science, and manufacturing disciplines.

Connor Campbell
Co-Founder and CEO
Connor is co-founder and CEO at Hadrian Biodefense and chairs the board at BlueDot Impact. He previously co-founded Osler Diagnostics and worked as a consultant at McKinsey and Company.
LinkedInJason Davis
Chemistry Professor
The round was backed by M&G Investments alongside existing supporters Oxford Science Enterprises, Braavos Investment Advisers, and Lansdowne Partners.